In the early days of the COVID-19 pandemic, confusion and concern for immunosuppressed patients grew among rheumatologists and patients alike. Research has helped bridge the knowledge gap, and treatment options for COVID-19 have helped ease concerns.
![](https://www.the-rheumatologist.org/wp-content/uploads/2024/03/AdobeStock_334601687-150x150.png)